Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Treatment of hyperphosphatemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis)
Age: Adult
Condition: Initial treatment
Dose: Oral Tablet – 1 tablet
Frequency: three times daily
Note: Adjusted according to serum-phosphate concentration
Indication: Treatment of hyperphosphatemia associated with chronic renal insufficiency in patients undergoing dialysis (haemodialysis, peritoneal dialysis)
Age: Adult
Condition: Maintenance treatment
Dose: Oral Tablet – 3–10 tablets
Frequency: daily
Note: Maximum 12 tablets per day

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available
Administration
  • Must be taken with meals
  • Do not chew tablets
Side Effect

Drug Interaction

Drug NameRisk Factors
Nitrofurantoin
May decrease bioavailability and anti-infective effect
Antibiotics (tetracyclines, doxycycline, norfloxacin, some Cephalosporins (Cephalothin, Cefazolin, Cefadroxil, Cefuroxime, Ceftriaxone, Cefotaxime), some quinolones)
Affects absorption

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.